Fuji Pharma Statistics

Total Valuation

Fuji Pharma has a market cap or net worth of JPY 33.25 billion. The enterprise value is 59.97 billion.

Market Cap	33.25B
Enterprise Value	59.97B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Fuji Pharma has 24.43 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	n/a
Shares Outstanding	24.43M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	41.41%
Owned by Institutions (%)	12.98%
Float	11.39M

Valuation Ratios

The trailing PE ratio is 7.52 and the forward PE ratio is 9.36.

PE Ratio	7.52
Forward PE	9.36
PS Ratio	0.69
PB Ratio	0.70
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	13.63
EV / Sales	1.24
EV / EBITDA	6.58
EV / EBIT	11.37
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.64.

Current Ratio	1.19
Quick Ratio	0.62
Debt / Equity	0.64
Debt / EBITDA	3.34
Debt / FCF	n/a
Interest Coverage	22.64

Financial Efficiency

Return on equity (ROE) is 9.80% and return on invested capital (ROIC) is 4.47%.

Return on Equity (ROE)	9.80%
Return on Assets (ROA)	3.69%
Return on Invested Capital (ROIC)	4.47%
Return on Capital Employed (ROCE)	9.42%
Revenue Per Employee	29.19M
Profits Per Employee	2.65M
Employee Count	1,658
Asset Turnover	0.54
Inventory Turnover	1.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.72% in the last 52 weeks. The beta is 0.25, so Fuji Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-14.72%
50-Day Moving Average	1,341.40
200-Day Moving Average	1,384.09
Relative Strength Index (RSI)	54.81
Average Volume (20 Days)	54,170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Fuji Pharma had revenue of JPY 48.39 billion and earned 4.40 billion in profits. Earnings per share was 180.88.

Revenue	48.39B
Gross Profit	19.60B
Operating Income	5.27B
Pretax Income	5.79B
Net Income	4.40B
EBITDA	9.12B
EBIT	5.27B
Earnings Per Share (EPS)	180.88

Full Income Statement

Balance Sheet

The company has 3.70 billion in cash and 30.41 billion in debt, giving a net cash position of -26.72 billion or -1,093.67 per share.

Cash & Cash Equivalents	3.70B
Total Debt	30.41B
Net Cash	-26.72B
Net Cash Per Share	-1,093.67
Equity (Book Value)	47.76B
Book Value Per Share	1,958.80
Working Capital	7.32B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 40.49%, with operating and profit margins of 10.90% and 9.09%.

Gross Margin	40.49%
Operating Margin	10.90%
Pretax Margin	11.97%
Profit Margin	9.09%
EBITDA Margin	18.84%
EBIT Margin	10.90%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 45.50, which amounts to a dividend yield of 3.34%.

Dividend Per Share	45.50
Dividend Yield	3.34%
Dividend Growth (YoY)	6.25%
Years of Dividend Growth	3
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	3.30%
Earnings Yield	13.23%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Fuji Pharma has an Altman Z-Score of 1.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	n/a